Display options
Cite
Reubi JC. Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology. Endocr Pathol. 1997;8(1):11-20doi: 10.1007/BF02739703.
Reubi, J. C. (1997). Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology. Endocrine pathology, 8(1), 11-20. https://doi.org/10.1007/BF02739703
Reubi, Jean Claude. "Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology." Endocrine pathology vol. 8,1 (1997): 11-20. doi: https://doi.org/10.1007/BF02739703
Reubi JC. Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology. Endocr Pathol. 1997;8(1):11-20. doi: 10.1007/BF02739703. PMID: 12114667.
Copy Download .nbib Format: NLM
Share it on

Endocr Pathol. 1997;8(1):11-20. doi: 10.1007/BF02739703.

Relevance of Somatostatin Receptors and Other Peptide Receptors in Pathology.

Endocrine pathology

Jean Claude Reubi

PMID: 12114667 DOI: 10.1007/BF02739703

Abstract

Receptors for regulatory peptides can be overexpressed by several diseases, in particular by neoplasms. This review summarizes the current status of knowledge in this field, on the basis of in vitro receptor studies and with emphasis on receptors for somatostatin as well as for substance P (SP), vasoactive intestinal polypeptide (VIP), and cholecystokinin. It evaluates the existing and potential clinical implications of the findings for diagnosis and therapy and discusses the role of the pathologist in this context.

References

  1. Cell Growth Differ. 1994 Jan;5(1):1-8 - PubMed
  2. J Nucl Med. 1995 Oct;36(10 ):1825-35 - PubMed
  3. Cancer Res. 1995 Jan 15;55(2):276-9 - PubMed
  4. Trends Pharmacol Sci. 1995 Mar;16(3):86-8 - PubMed
  5. J Clin Endocrinol Metab. 1994 Sep;79(3):724-9 - PubMed
  6. Am J Pathol. 1989 Feb;134(2):337-44 - PubMed
  7. Eur J Nucl Med. 1994 Jun;21(6):497-502 - PubMed
  8. Metabolism. 1992 Sep;41(9 Suppl 2):104-10 - PubMed
  9. Peptides. 1996;17(3):545-55 - PubMed
  10. Cancer Res. 1994 Jul 1;54(13):3455-9 - PubMed
  11. Ann Rheum Dis. 1992 Mar;51(3):313-7 - PubMed
  12. N Engl J Med. 1994 Oct 27;331(17 ):1116-21 - PubMed
  13. J Clin Invest. 1996 Apr 15;97(8):1874-83 - PubMed
  14. Cancer Res. 1996 Apr 15;56(8):1823-7 - PubMed
  15. Dis Markers. 1996 Mar;12(4):225-40 - PubMed
  16. Endocr Rev. 1991 Nov;12(4):450-82 - PubMed
  17. Int J Cancer. 1995 Jun 9;61(6):786-92 - PubMed
  18. Trends Pharmacol Sci. 1995 Mar;16(3):110-5 - PubMed
  19. Gastroenterology. 1994 Apr;106(4):951-9 - PubMed
  20. Yale J Biol Med. 1992 Sep-Oct;65(5):505-18; discussion 531-6 - PubMed
  21. Int J Cancer. 1996 Sep 4;67(5):644-7 - PubMed
  22. Proc Natl Acad Sci U S A. 1988 May;85(9):3235-9 - PubMed
  23. Endocr Rev. 1995 Aug;16(4):427-42 - PubMed
  24. Am J Clin Pathol. 1994 Dec;102(6):752-6 - PubMed
  25. J Clin Endocrinol Metab. 1995 Sep;80(9):2806-14 - PubMed
  26. J Nucl Med. 1995 Oct;36(10 ):1846-53 - PubMed

Publication Types